D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
IBM
IBM
|
+$327M |
| 2 |
James River Group
JRVR
|
+$320M |
| 3 |
Marathon Petroleum
MPC
|
+$246M |
| 4 |
Phillips 66
PSX
|
+$245M |
| 5 |
DuPont de Nemours
DD
|
+$237M |
Top Sells
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Alibaba
BABA
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$410M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$305M |
| 5 |
Micron Technology
MU
|
+$281M |
Sector Composition
| 1 | Technology | 12.56% |
| 2 | Consumer Discretionary | 12.24% |
| 3 | Energy | 12.13% |
| 4 | Healthcare | 10.46% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRESW
2351
DELISTED
CRESUD S.A.C.I.F. YA WTS ON SHS
CRESW
| $140K | ﹤0.01% |
11,139,520
| – | – |
|
|
ENZ
2352
DELISTED
Enzo Biochem, Inc.
ENZ
| $139K | ﹤0.01% |
31,332
-14,764
| -32% | -$65.5K |
|
|
NSPH
2353
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $137K | ﹤0.01% |
+17,500
| New | +$137K |
|
2354
Odyssey Marine Exploration
OMEX
$72.3M
| $136K | ﹤0.01% |
12,184
+7,130
| +141% | +$79.6K |
|
|
TEN
2355
Tsakos Energy Navigation Ltd.
TEN
$690M
| $131K | ﹤0.01% |
+3,760
| New | +$131K |
|
2356
QuickLogic
QUIK
$83.3M
| $130K | ﹤0.01% |
+2,947
| New | +$130K |
|
2357
Oramed Pharmaceuticals
ORMP
$94.3M
| $126K | ﹤0.01% |
27,708
+10,705
| +63% | +$48.7K |
|
2358
PhenixFIN
PFX
$96.4M
| $126K | ﹤0.01% |
682
-10,255
| -94% | -$1.89M |
|
|
SFXE
2359
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
| $125K | ﹤0.01% |
27,544
-42,962
| -61% | -$195K |
|
|
TEAR
2360
DELISTED
TearLab Corporation
TEAR
| $121K | ﹤0.01% |
+4,571
| New | +$121K |
|
2361
Lineage Cell Therapeutics
LCTX
$290M
| $119K | ﹤0.01% |
39,517
+3,064
| +8% | +$9.23K |
|
2362
LifeVantage
LFVN
$150M
| $119K | ﹤0.01% |
13,066
+11,159
| +585% | +$102K |
|
2363
AudioCodes
AUDC
$281M
| $118K | ﹤0.01% |
+25,968
| New | +$118K |
|
2364
TherapeuticsMD
TXMD
$12.5M
| $118K | ﹤0.01% |
+530
| New | +$118K |
|
|
AUO
2365
DELISTED
AU Optronics Corp
AUO
| $115K | ﹤0.01% |
22,661
-131,468
| -85% | -$667K |
|
2366
Imunon
IMNN
$14.7M
| $114K | ﹤0.01% |
18
-34
| -65% | -$215K |
|
2367
Orion Group Holdings
ORN
$286M
| $113K | ﹤0.01% |
+10,247
| New | +$113K |
|
2368
Ryerson Holding
RYI
$736M
| $113K | ﹤0.01% |
11,368
-32,660
| -74% | -$325K |
|
|
ARR
2369
Armour Residential REIT
ARR
$1.77B
| $111K | ﹤0.01% |
751
-363
| -33% | -$53.7K |
|
|
NCIT
2370
DELISTED
NCI, Inc.
NCIT
| $110K | ﹤0.01% |
10,744
-800
| -7% | -$8.19K |
|
|
RSYS
2371
DELISTED
Radisys Corp
RSYS
| $108K | ﹤0.01% |
46,194
-6,800
| -13% | -$15.9K |
|
2372
Traws Pharma
TRAW
$13.1M
| $107K | ﹤0.01% |
+1
| New | +$107K |
|
|
ADNC
2373
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
| $107K | ﹤0.01% |
24,390
-17,395
| -42% | -$76.3K |
|
2374
Lisata Therapeutics
LSTA
$19.1M
| $106K | ﹤0.01% |
187
+49
| +36% | +$27.8K |
|
|
CETV
2375
DELISTED
Central European Media Enterprises Ltd
CETV
| $101K | ﹤0.01% |
31,500
-11,169
| -26% | -$35.8K |
|